Rikke Mette Agesen (Rikke M Agesen)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 3

Top Venues

Diabetes technology & therapeutics

BMC endocrine disorders

Diabetologia

This page only lists publications with an associated author ORCID identifier.

Publications

Xiantong Zou, Rikke Mette Agesen, Stephen C Bain, Fangming Fu, Sanaz Gabery, Jianlin Geng, Yiming Li, Yibing Lu, Bifen Luo, Wuyan Pang, Yi Tao, null null
Efficacy and safety of oral semaglutide vs sitagliptin in a predominantly Chinese population with type 2 diabetes uncontrolled with metformin: PIONEER 12, a double-blind, Phase IIIa, randomised trial. Diabetologia (2024)
Julie Maria Bøggild Brøsen, Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Georg Riber Hedetoft, Tonny Joran Jensen, Charlotte Røn Stolberg, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans-Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia. Diabetes technology & therapeutics 24 (9) (2022)
Rikke Mette Agesen, Amra Ciric Alibegovic, Henrik Ullits Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels Krarup Hansen, Christoffer Hedetoft, Tonny Jensen, Claus Bogh Juhl, Susanne Søgaard Lerche, Kirsten Nørgaard, Hans-Henrik Parving, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design. BMC endocrine disorders 19 (1) (2019)

Rikke Mette Agesen.css-eqlu8i{font-size:small;padding-left:4px;} (Rikke M Agesen)

Publication Activity (10 Years)

Top Topics

Top Venues

Rikke Mette Agesen (Rikke M Agesen)